Filing Details
- Accession Number:
- 0001213900-17-010332
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-10-05 18:05:04
- Reporting Period:
- 2017-10-05
- Accepted Time:
- 2017-10-05 18:05:04
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1498382 | Delmar Pharmaceuticals Inc. | DMPI | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1332948 | Scott Praill | Suite 720-999 West Broadway Vancouver A1 V5Z 1K5 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-10-05 | 17,500 | $0.85 | 47,366 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
